Index - P/E - EPS (ttm) -0.94 Insider Own 52.63% Shs Outstand 17.05M Perf Week 52.73%
Market Cap 74.08M Forward P/E - EPS next Y -0.67 Insider Trans 0.50% Shs Float 8.35M Perf Month 48.41%
Income -16.93M PEG - EPS next Q -0.26 Inst Own 36.26% Short Float 0.63% Perf Quarter 37.70%
Sales 55.75M P/S 1.33 EPS this Y 33.30% Inst Trans 1.82% Short Ratio 1.30 Perf Half Y 124.60%
Book/sh 0.73 P/B 5.72 EPS next Y 25.45% ROA -32.39% Short Interest 0.05M Perf Year 169.23%
Cash/sh 1.25 P/C 3.36 EPS next 5Y - ROE -83.86% 52W Range 1.30 - 4.23 Perf YTD 111.06%
Dividend Est. - P/FCF - EPS past 5Y 2.69% ROI -48.86% 52W High -0.71% Beta 1.43
Dividend TTM - Quick Ratio 3.72 Sales past 5Y 10.63% Gross Margin 58.80% 52W Low 223.00% ATR (14) 0.30
Dividend Ex-Date - Current Ratio 4.05 EPS Y/Y TTM 49.65% Oper. Margin -27.62% RSI (14) 80.15 Volatility 15.83% 9.49%
Employees 179 Debt/Eq 1.83 Sales Y/Y TTM 8.00% Profit Margin -30.36% Recom 1.33 Target Price 6.25
Option/Short Yes / Yes LT Debt/Eq 1.69 EPS Q/Q 10.03% Payout - Rel Volume 0.00 Prev Close 4.20
Sales Surprise -7.85% EPS Surprise 3.38% Sales Q/Q -6.78% Earnings Nov 12 BMO Avg Volume 40.27K Price 4.20
SMA20 49.30% SMA50 47.17% SMA200 89.18% Trades
Volume 0 Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-05-22 Downgrade KeyBanc Capital Markets
Overweight → Sector Weight
Oct-15-21 Resumed Cowen
Outperform
$26
Apr-15-21 Initiated Canaccord Genuity
Buy
$25
Nov-10-20 Initiated KeyBanc Capital Markets
Overweight
$32
Oct-08-20 Initiated BTIG Research
Buy
$18
Jun-02-20 Resumed Cantor Fitzgerald
Overweight
$19 → $20
Oct-14-19 Initiated William Blair
Outperform
Oct-14-19 Initiated Cowen
Outperform
$17
Oct-14-19 Initiated Cantor Fitzgerald
Overweight
$18
Nov-14-24 04:30PM
Nov-13-24 04:05PM
02:09AM
12:51AM
(Thomson Reuters StreetEvents)
Nov-12-24 09:25AM
07:25AM
Loading…
Nov-11-24 07:25AM
Oct-29-24 04:05PM
Oct-21-24 04:05PM
Sep-04-24 04:05PM
Aug-29-24 09:55AM
Aug-26-24 08:50AM
Aug-09-24 09:15AM
Aug-08-24 08:50AM
Aug-05-24 12:53PM
09:10AM
08:00AM
Loading…
08:00AM
Aug-02-24 09:00AM
Aug-01-24 09:00AM
Jul-22-24 09:00AM
Jun-13-24 08:50AM
May-15-24 05:01AM
May-13-24 12:53PM
09:10AM
08:00AM
May-06-24 04:05PM
Apr-30-24 04:05PM
Apr-26-24 08:30AM
Mar-19-24 09:37AM
01:55AM
(Thomson Reuters StreetEvents)
Mar-18-24 12:52PM
09:25AM
Loading…
09:25AM
08:00AM
Mar-08-24 09:00AM
Mar-07-24 04:05PM
Feb-06-24 08:50AM
Jan-30-24 04:05PM
Jan-07-24 12:00PM
Nov-13-23 04:05PM
Nov-09-23 04:05PM
Nov-02-23 04:05PM
Oct-30-23 04:05PM
(GlobeNewswire) +6.75%
+6.08%
Sep-28-23 04:05PM
Sep-12-23 04:05PM
Aug-09-23 10:47AM
Aug-08-23 04:13AM
(Thomson Reuters StreetEvents)
Aug-07-23 09:15AM
08:00AM
Jul-26-23 04:05PM
Jul-25-23 04:05PM
Jul-24-23 04:05PM
07:33AM
Jun-13-23 08:19AM
May-30-23 09:00AM
May-17-23 07:11AM
May-16-23 11:03AM
(Thomson Reuters StreetEvents) +19.51%
May-15-23 05:55PM
04:05PM
May-01-23 04:05PM
Apr-24-23 04:05PM
Mar-24-23 08:16AM
Mar-22-23 06:12AM
Mar-21-23 07:40AM
(Thomson Reuters StreetEvents)
Mar-20-23 05:25PM
04:05PM
Mar-06-23 04:05PM
Feb-27-23 09:00AM
Feb-14-23 06:19AM
Jan-30-23 04:05PM
Jan-23-23 09:00AM
Nov-14-22 07:55PM
04:05PM
Nov-08-22 04:05PM
Oct-31-22 04:05PM
Oct-17-22 09:00AM
Oct-04-22 08:25AM
Sep-20-22 04:05PM
Sep-19-22 10:20AM
Sep-01-22 04:05PM
Aug-05-22 12:00PM
Aug-04-22 06:55PM
04:06PM
04:05PM
Jul-25-22 04:05PM
(GlobeNewswire) +8.23%
-6.11%
Jul-21-22 04:05PM
Jul-05-22 08:25AM
Jun-21-22 08:10AM
Jun-09-22 08:25AM
May-26-22 04:05PM
May-16-22 04:05PM
May-11-22 05:55PM
04:06PM
04:05PM
May-10-22 10:45AM
May-03-22 05:15PM
May-01-22 12:00PM
Apr-25-22 04:05PM
Apr-20-22 04:05PM
Apr-12-22 07:22AM
Mar-30-22 08:25AM
Mar-22-22 10:00PM
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Black Jeffrey G. Chief Financial Officer Nov 15 '24 Buy 2.98 22,298 66,448 274,492 Nov 19 07:24 PM ABALLI JOHN President and CEO Nov 14 '24 Buy 2.81 24,305 68,297 689,799 Nov 18 06:32 PM Adawi Kamal Officer Oct 08 '24 Proposed Sale 2.94 84,162 247,436 Oct 08 04:39 PM Adawi Kamal Officer Aug 09 '24 Proposed Sale 2.76 52,624 145,242 Aug 09 05:08 PM ABALLI JOHN President and CEO May 16 '24 Buy 1.92 40,401 77,570 40,401 May 16 08:02 PM Adawi Kamal CFO and Corporate Secretary Mar 04 '24 Sale 1.91 12,784 24,407 243,749 Mar 06 04:05 PM Adawi Kamal CFO and Corporate Secretary Feb 06 '24 Sale 1.95 6,738 13,133 181,533 Feb 08 04:05 PM
Index RUT P/E - EPS (ttm) -0.71 Insider Own 3.24% Shs Outstand 372.26M Perf Week -12.50%
Market Cap 599.34M Forward P/E - EPS next Y -0.20 Insider Trans 196.62% Shs Float 360.19M Perf Month -12.50%
Income -170.60M PEG - EPS next Q -0.06 Inst Own 75.15% Short Float 5.43% Perf Quarter -17.44%
Sales 155.90M P/S 3.84 EPS this Y 62.06% Inst Trans 3.27% Short Ratio 10.30 Perf Half Y -37.84%
Book/sh 1.31 P/B 1.22 EPS next Y 43.93% ROA -24.41% Short Interest 19.54M Perf Year -29.07%
Cash/sh 0.98 P/C 1.64 EPS next 5Y -8.06% ROE -69.68% 52W Range 1.21 - 3.04 Perf YTD -27.15%
Dividend Est. - P/FCF - EPS past 5Y 8.72% ROI -32.95% 52W High -47.04% Beta 1.61
Dividend TTM - Quick Ratio 3.41 Sales past 5Y -0.06% Gross Margin 48.57% 52W Low 33.06% ATR (14) 0.15
Dividend Ex-Date - Current Ratio 3.76 EPS Y/Y TTM 25.93% Oper. Margin -76.92% RSI (14) 38.92 Volatility 9.71% 8.43%
Employees 539 Debt/Eq 0.18 Sales Y/Y TTM 48.23% Profit Margin -109.43% Recom 1.00 Target Price 3.08
Option/Short Yes / Yes LT Debt/Eq 0.06 EPS Q/Q 72.67% Payout - Rel Volume 0.00 Prev Close 1.61
Sales Surprise 9.68% EPS Surprise 22.22% Sales Q/Q 77.27% Earnings Oct 30 AMC Avg Volume 1.90M Price 1.61
SMA20 -14.16% SMA50 -14.87% SMA200 -26.71% Trades
Volume 0 Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-16-24 Initiated TD Cowen
Buy
$3.50
Apr-04-24 Initiated Jefferies
Buy
$3.25
Jul-12-23 Initiated KeyBanc Capital Markets
Overweight
$4
Nov-07-24 08:00AM
Oct-31-24 11:00AM
08:01AM
Oct-30-24 05:20PM
04:15PM
(Associated Press Finance)
04:01PM
Loading…
04:01PM
Oct-21-24 09:03PM
Oct-16-24 08:00AM
Oct-03-24 04:56AM
Sep-24-24 08:00AM
Sep-18-24 08:00AM
Aug-26-24 08:00AM
Aug-23-24 06:03PM
Aug-06-24 04:01PM
Aug-01-24 09:14AM
(Thomson Reuters StreetEvents) -36.61%
09:57PM
Loading…
Jul-31-24 09:57PM
05:40PM
04:36PM
(Associated Press Finance)
04:02PM
04:01PM
Jul-17-24 08:01AM
May-28-24 04:01PM
May-22-24 04:01PM
May-20-24 08:00AM
May-13-24 10:45AM
May-08-24 08:59PM
(InvestorPlace) -5.49%
+7.59%
04:33PM
(Associated Press Finance)
04:01PM
Apr-25-24 11:27AM
08:01AM
08:00AM
Loading…
08:00AM
Apr-08-24 08:00AM
Apr-03-24 04:01PM
Mar-18-24 08:12AM
Mar-05-24 08:27AM
Feb-29-24 06:29AM
(Thomson Reuters StreetEvents) -5.06%
Feb-28-24 04:41PM
04:16PM
(Associated Press Finance)
04:01PM
Feb-26-24 08:00AM
Feb-22-24 04:05PM
Feb-14-24 08:30AM
Feb-07-24 08:30AM
Jan-08-24 08:30AM
Jan-05-24 08:46AM
Jan-04-24 10:23PM
09:44PM
Dec-29-23 05:04PM
Dec-28-23 04:16PM
Dec-26-23 03:59PM
Dec-22-23 06:57PM
Dec-21-23 08:00AM
Dec-20-23 09:00AM
Dec-17-23 03:37PM
Dec-12-23 04:32PM
Dec-11-23 10:37AM
Dec-06-23 11:18AM
Dec-04-23 08:00AM
Nov-09-23 05:54AM
(Thomson Reuters StreetEvents) +6.84%
Nov-08-23 12:47PM
06:52AM
(Thomson Reuters StreetEvents)
Nov-07-23 04:23PM
(Associated Press Finance)
04:00PM
Nov-02-23 08:30AM
Oct-25-23 08:30AM
Oct-10-23 10:22AM
Oct-05-23 02:42PM
Oct-04-23 06:49PM
08:52AM
08:00AM
Aug-09-23 09:06AM
(Thomson Reuters StreetEvents) +7.56%
Aug-08-23 05:36PM
(Associated Press Finance)
04:05PM
Jul-26-23 04:05PM
Jul-25-23 04:05PM
Jul-13-23 07:33AM
Jun-14-23 07:30AM
Jun-13-23 01:30PM
May-25-23 04:05PM
May-24-23 07:11AM
06:05AM
May-18-23 07:30AM
May-15-23 07:30AM
May-10-23 02:47PM
06:16AM
(Thomson Reuters StreetEvents)
May-09-23 06:11PM
04:05PM
Apr-25-23 04:30PM
Apr-20-23 05:03PM
Apr-18-23 10:42AM
Apr-17-23 08:30AM
Mar-22-23 08:30AM
Mar-15-23 08:30AM
Mar-14-23 08:30AM
Mar-01-23 04:05PM
Feb-21-23 08:30AM
Feb-17-23 06:43PM
Feb-15-23 06:01PM
(American City Business Journals)
Feb-14-23 04:05PM
Feb-03-23 05:30AM
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Black Jeffrey G. Former Officer Nov 12 '24 Proposed Sale 2.12 57,971 123,098 Nov 12 04:13 PM Taich Adam Former Officer Sep 09 '24 Proposed Sale 2.00 45,851 91,725 Sep 09 03:19 PM Casdin Partners Master Fund, L Director Aug 27 '24 Buy 2.19 250,000 546,750 54,025,821 Aug 29 08:30 PM Casdin Partners Master Fund, L Director Aug 23 '24 Buy 2.13 292,100 620,975 53,625,821 Aug 26 08:10 PM Casdin Partners Master Fund, L Director Aug 22 '24 Buy 1.96 307,900 602,807 53,333,721 Aug 26 08:10 PM Casdin Partners Master Fund, L Director Aug 26 '24 Buy 2.15 150,000 322,455 53,775,821 Aug 26 08:10 PM Casdin Partners Master Fund, L Director Aug 21 '24 Buy 1.90 500,000 951,950 53,025,821 Aug 21 08:47 PM Casdin Partners Master Fund, L Director Aug 20 '24 Buy 1.87 500,000 936,700 52,525,821 Aug 21 08:47 PM Casdin Partners Master Fund, L Director Aug 19 '24 Buy 1.85 250,000 463,225 52,025,821 Aug 21 08:47 PM Black Jeffrey G. SVP & Chief Financial Officer Aug 15 '24 Option Exercise 0.00 13,157 0 432,993 Aug 19 05:30 PM Casdin Partners Master Fund, L Director Aug 14 '24 Buy 1.59 1,200,000 1,913,520 51,775,821 Aug 16 07:52 PM Casdin Partners Master Fund, L Director Aug 13 '24 Buy 1.62 550,000 890,560 50,575,821 Aug 13 08:15 PM Casdin Partners Master Fund, L Director Aug 09 '24 Buy 1.61 525,408 848,481 49,525,821 Aug 13 08:15 PM Casdin Partners Master Fund, L Director Aug 12 '24 Buy 1.64 500,000 820,600 50,025,821 Aug 13 08:15 PM Casdin Partners Master Fund, L Director Aug 08 '24 Buy 1.64 569,562 932,601 49,000,413 Aug 09 09:34 PM Casdin Partners Master Fund, L Director Aug 07 '24 Buy 1.57 500,000 786,200 48,430,821 Aug 09 09:34 PM Casdin Partners Master Fund, L Director Aug 02 '24 Buy 1.63 1,000,000 1,631,900 47,730,821 Aug 06 09:58 PM Casdin Partners Master Fund, L Director Aug 05 '24 Buy 1.58 200,000 316,780 47,930,821 Aug 06 09:58 PM Casdin Partners Master Fund, L Director May 23 '24 Buy 2.60 100,000 260,000 46,075,821 May 28 08:45 PM Casdin Partners Master Fund, L Director May 21 '24 Buy 2.56 350,000 895,930 45,825,821 May 22 07:53 PM Casdin Partners Master Fund, L Director May 22 '24 Buy 2.58 150,000 387,735 45,975,821 May 22 07:53 PM Casdin Partners Master Fund, L Director May 20 '24 Buy 2.58 100,000 258,130 45,475,821 May 22 07:53 PM Casdin Partners Master Fund, L Director May 15 '24 Buy 2.57 500,000 1,282,550 44,523,749 May 17 08:11 PM Casdin Partners Master Fund, L Director May 16 '24 Buy 2.54 500,000 1,270,950 45,023,749 May 17 08:11 PM Casdin Partners Master Fund, L Director May 17 '24 Buy 2.56 352,072 902,044 45,375,821 May 17 08:11 PM Black Jeffrey G. SVP & Chief Financial Officer May 15 '24 Option Exercise 0.00 52,631 0 138,615 May 16 09:07 PM Egholm Michael President & CEO Apr 04 '24 Option Exercise 0.00 196,512 0 422,030 Apr 05 06:59 PM Kim Hanjoon Alex Chief Operating Officer Apr 04 '24 Option Exercise 0.00 70,183 0 140,366 Apr 05 06:58 PM Casdin Partners Master Fund, L Director Mar 04 '24 Buy 2.57 250,000 642,500 11,496,525 Mar 06 07:20 PM Casdin Partners Master Fund, L Director Mar 05 '24 Buy 2.62 1,403 3,669 11,497,928 Mar 06 07:20 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
